To order thisdetailed 180+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/peptides-and-macrocycle-discovery/300.html
Key Inclusions
§ A detailed assessment of the current market landscape ofcompanies offering peptide and macrocycle drug discovery services, includingdeveloper information (year of establishment, company size and location ofheadquarters), type of peptide manufactured (linear, cyclic, helical andothers), drug discovery steps covered in service portfolio (target validation,hit identification, lead generation and lead optimization), peptide generationmethods used (liquid phase synthesis, solid phase synthesis, microwave-assistedsynthesis, recombinant methods and others), peptide modification services(C-terminal, N-terminal, fret / quenching tags, immunogenic conjugates, linkers/ spacers, unnatural AAS, cyclization, stable isotope labels andpost-translational modification services) and other services offered (peptideisolation / purification service, peptide detection / identification serviceand peptide quantification service).
§ An insightfulgeographical benchmarking of the capabilities of companies of various sizes,highlighting the key focus areas, comparing their existing strengths bothwithin and beyond their respective peer groups (based on geography and companysize).
§ An in-depth analysisof peptide platform and library service providers, featuring information ontheir company details (year of establishment, company size and location ofheadquarters), purpose of the platform, type of peptide manufactured (linear,cyclic, helical and others) and platform access model (pipeline licensing,technology licensing, strategic alliance and library provider).
§ Profiles of peptides andmacrocycle drug discovery service providers, featuring information on the yearof establishment, location of headquarters, peptide discovery service /platform portfolio, recent developments, and an informed future outlook.
§ An analysis of the partnershipsthat have been established in the recent past, covering mergers andacquisitions, research collaborations, R&D agreements, licensing agreements(related to both technology platforms and service providers) and other form ofcollaborations.
§ An analysis of proprietarydisplay technologies developed by different drug discovery technologyproviders, based on the 2X2 matrix.
§ Informed estimates of theexisting market size and the future opportunity for peptides and macrocycledrug discovery service and platform providers, over the next decade. Based onmultiple parameters, such as total pharmaceutical R&D market, biologicalpipeline, peptide drugs pipeline and drug discovery outsourcing percentage, wehave provided informed estimates on the evolution of the market for the period2020-2030.
The report alsofeatures the likely distribution of the current and forecasted opportunityacross important market segments, mentioned below:
§ Type of peptides
§ Synthetic peptides
§ Biologic andrecombinant peptides
§ Type of discovery steps
§ Target identificationand validation
§ Hit identification
§ Lead generation
§ Lead optimization
§ Therapeutic Area
§ Oncological disorders
§ Metabolic disorders
§ Cardiovasculardisorders
§ Infectious diseases
§ Urological disorders
§ Endocrine disorders
§ CNS disorders
§ Other diseases
§ Company Size
§ Small companies
§ Mid-sized companies
§ Large and very largecompanies
§ Key geographicalregions
§ Europe
§ North America
§ Asia-Pacific and theRest of the World
To request samplepages, please visit this https://www.rootsanalysis.com/reports/300/request-sample.html
Key QuestionsAnswered
§ Whoare the key service providers for peptide discovery?
§ Whoare the key service providers for macrocycle drug discovery?
§ Whoare the service providers that can synthesize peptide and macrocycle libraries?
§ Whatis the outsourcing trend in the peptides and macrocycle drug discovery?
§ Howis the current and future market opportunity likely to be distributed acrosskey market segments based on the services market?
§ Whatare the promising technology platforms that are available for the discovery ofpeptides and macrocyclic drugs?
§ Whatare the various trends in partnerships and licensing activity in this domain?
§ Whatare the strengths, weakness, opportunities, and threats in this industry?
You may also beinterested in the following titles:
1. 1DNA-Encoded Libraries: Platformsand Services Market, 2020–2030
2. Antibody ContractManufacturing Market, 2020 – 2030
3. Global AutoinjectorsMarket, 2020-2030
Contact Us
Gaurav Chaudhary
+1 (415) 800 3415
